Hepatology and Biliary Tract Diseases Flashcards
Diagnosis suggested by elevated alkaline phosphatase and positive antimitochondrial antibody
PBC
MKSAP 20
PBC stands for Primary Biliary Cholangitis.
Mandatory test in patients with cirrhosis with new-onset ascites
Diagnostic paracentesis
MKSAP 20
This procedure helps to evaluate the cause of ascites.
HCV-associated extrahepatic diseases
Non-Hodgkin lymphoma, membranoproliferative glomerulonephritis, mixed cryoglobulinemia, porphyria cutanea tarda
MKSAP 20
These are conditions that can occur outside the liver due to hepatitis C.
Recommended hepatitis C pretreatment assessment
Cirrhosis assessment with serologic biomarkers and/or elastography
MKSAP 20
This assessment is critical to determine the extent of liver disease before starting treatment.
Ascites leukocyte count diagnostic for SBP
≥250/µL
MKSAP 20
SBP stands for spontaneous bacterial peritonitis.
Most common causes of drug-induced liver injury
Acetaminophen, amoxicillin-clavulanate, phenytoin, valproate
MKSAP 20
These medications are frequently associated with liver toxicity.
Treatment for liver disease and iron overload secondary to hereditary hemochromatosis
Phlebotomy
MKSAP 20
This treatment helps to reduce iron levels in the body.
HCC screening in at-risk patients with hepatitis B and no cirrhosis
Ultrasonography and AFP measurement every 6 months
MKSAP 20
HCC stands for hepatocellular carcinoma, and AFP is alpha-fetoprotein.
Most common cause of abnormal liver test results
MASLD
MKSAP 20
MASLD stands for Metabolic Associated Steatotic Liver Disease.
Amebic liver abscess diagnostic tests
Liver imaging, E. histolytica serologic testing
MKSAP 20
E. histolytica is the causative agent of amebic liver abscess.
Diagnosis characterized by cirrhosis-related orthodeoxia and platypnea
Hepatopulmonary syndrome
MKSAP 20
This syndrome involves respiratory complications due to liver disease.
Alcoholic hepatitis indications for prednisolone
MELD score >20
MKSAP 20
MELD stands for Model for End-Stage Liver Disease.
PSC cancer associations
Cholangiocarcinoma, colorectal cancer, gallbladder cancer
MKSAP 20
PSC stands for Primary Sclerosing Cholangitis.
Hepatitis C–related vasculitis
Mixed cryoglobulinemia
MKSAP 20
This condition is associated with the presence of cryoglobulins in the blood.
MASLD treatment
Weight loss, diet modification, and moderate exercise
MKSAP 20
These lifestyle changes are essential for managing MASLD.
Diagnosis suggested by first-trimester pregnancy, prolonged vomiting, elevated AST/ALT
Hyperemesis gravidarum
MKSAP 20
This condition involves severe nausea and vomiting during pregnancy.
USPSTF hepatitis C screening indication
All patients age 18-79 years
MKSAP 20
USPSTF stands for United States Preventive Services Task Force.
Diagnosis suggested by fever, jaundice, tender hepatomegaly, alcohol use disorder, abdominal distention from ascites
Alcoholic hepatitis
MKSAP 20
This condition results from excessive alcohol consumption leading to liver inflammation.
Most common antibiotic causing cholestatic liver damage
Amoxicillin-clavulanate
MKSAP 20
This antibiotic combination is known for its potential liver toxicity.
Test for acute cholecystitis if high clinical likelihood but negative ultrasound
HIDA scan
MKSAP 20
HIDA stands for hepatobiliary iminodiacetic acid scan.
Diagnosis suggested by second- or third-trimester pregnancy, pruritus, mild AST/ALT elevations
Intrahepatic cholestasis of pregnancy
MKSAP 20
This condition causes itching and is related to liver function during pregnancy.
Cirrhosis-related bone disease and screening test
Osteoporosis, DXA
MKSAP 20
DXA stands for dual-energy X-ray absorptiometry, a test for bone density.
Diagnosis suggested by fever, RUQ abdominal pain, jaundice
Cholangitis
MKSAP 20
This condition involves infection of the bile duct.
Treatment for autoimmune hepatitis
Prednisone, usually with azathioprine
MKSAP 20
This treatment regimen helps to manage autoimmune inflammation in the liver.
Diagnosis suggested by hepatomegaly, caudate lobe hypertrophy, ascites, RUQ pain
Budd-Chiari syndrome
MKSAP 20
This syndrome is caused by hepatic vein obstruction.
Most common cause of ALF
Acetaminophen overdose
MKSAP 20
Hepatitis B treatment indications
ALF, immune-active or reactivation phase, immunosuppression, cirrhosis, pregnant patients with viral load >200,000 U/mL in third trimester
MKSAP 20
Differential diagnosis for Gilbert syndrome
Hemolysis, drug-induced hyperbilirubinemia
MKSAP 20
Treatment for SBP
Third-generation cephalosporin plus albumin
MKSAP 20
Diagnostic testing for chronic hepatitis C
HCV antibody followed by HCV RNA
MKSAP 20
PBC treatment
Ursodeoxycholic acid
MKSAP 20
HCC screening test in patients with cirrhosis
Ultrasonography and AFP measurement every 6 months
MKSAP 20
Hepatitis B first-line treatments
Entecavir or tenofovir
MKSAP 20
Causes of high elastography scores
ALT >100 U/L, hepatic congestion or severe steatosis, infiltrative disorders, bile duct obstruction
MKSAP 20
Diagnosis suggested by normal ALT/AST, positive HBsAg, positive HBeAg, high HBV DNA
Hepatitis B infection immune-tolerant phase
MKSAP 20
Recommended tests for suspected liver fibrosis and cirrhosis
AST-to-platelet ratio index, Fibrosis-4 score, and elastography
MKSAP 20
Focal nodular hyperplasia treatment
None
MKSAP 20
Cholecystectomy indications for asymptomatic gallstones
Gallstones >3 cm, porcelain gallbladder, gallbladder polyp >1 cm
MKSAP 20
Liver transplantation indications
Acute liver failure, MELD 3.0 score ≥15, decompensated cirrhosis, or hepatocellular carcinoma
MKSAP 20
Diagnostic criterion for acute hepatitis A
HAV IgM antibodies
MKSAP 20
Bowel disease associated with PSC
IBD
MKSAP 20
Diagnosis suggested by ALF, neuropsychiatric symptoms, Coombs-negative hemolytic anemia in patient <40 years
Wilson disease
MKSAP 20
Diagnosis suggested by RUQ pain without gallstones on ultrasound in critically ill patient
Acalculous cholecystitis
MKSAP 20
Medical treatment for ascites
Sodium restriction, spironolactone, furosemide
MKSAP 20
Common autoimmune hepatitis antibodies
ANA and smooth-muscle antibody
MKSAP 20
Hepatic tumor associated with oral contraceptive agent in women
Hepatic adenoma
MKSAP 20
Treatment for HELLP syndrome and fatty liver of pregnancy
Delivery
MKSAP 20
PSC ERCP indications
Dominant stricture, bile duct mass
MKSAP 20
Hepatitis B–associated vasculitides
Polyarteritis nodosa, cryoglobulinemia
MKSAP 20
Intrahepatic cholestasis of pregnancy treatment
Ursodeoxycholic acid
MKSAP 20
Hepatitis B vertical transmission prevention drugs
Lamivudine, tenofovir
MKSAP 20
Common hepatic encephalopathy precipitants
Infection, GI bleeding, medications, volume depletion
MKSAP 20
Hepatic encephalopathy drug treatments
Lactulose (initial), rifaximin (second)
MKSAP 20
Diagnosis suggested by acute hepatitis and hemolytic anemia in a young adult
Wilson disease
MKSAP 20
Obstructive cholangitis treatment
Antibiotics and ERCP
MKSAP 20
PSC gold standard treatment
Liver transplantation
MKSAP 20
Test for all patients with cirrhosis not receiving nonselective β-blocker
Upper endoscopy to assess for varices
MKSAP 20
SBP prophylaxis after an episode of SBP
Long-term antibiotics
MKSAP 20
Hepatitis C treatment indication
All patients with infection (unless short life expectancy)
MKSAP 20
Hepatopulmonary syndrome test
Echocardiography with administration of agitated saline
MKSAP 20